Table 2.
Study reference | Chemotherapy regimens reported |
---|---|
Brooks et al. [23] |
Platinum/paclitaxel Platinum/pemetrexed Platinum/etoposide Platinum/gemcitabine Pemetrexed alone Paclitaxel alone IL-10 Pembrolizumab Erlotinib |
Friedes et al. [22] |
Platinum-based sensitising Platinum-based double/ single agent |
Terada et al. [14] |
Cisplatin/S-1 Cisplatin/vinorelbine Carboplatin/paclitaxel |
Lee et al. [15] |
Cisplatin/paclitaxel Cisplatin/docetaxel Cisplatin/etoposide Carboplatin/paclitaxel |